Helminth therapy or elimination: Epidemiological, immunological, and clinical considerations

The Lancet Infectious Diseases

Volumn 14, Issue 11, 2014, Pages 1150-1162

  Wammes, Linda J ^a   Mpairwe, Harriet ^b   Elliott, Alison M ^b,c   Yazdanbakhsh, Maria ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHELMINTIC AGENT;

ALLERGIC RHINITIS; ALLERGY; ANTIMICROBIAL THERAPY; ASTHMA; ATOPY; AUTISM; CELIAC DISEASE; DEWORMING; DIABETES MELLITUS; DISEASE ASSOCIATION; DOWN REGULATION; HELMINTHIASIS; HOMEOSTASIS; HUMAN; IMMUNOREGULATION; IMMUNOTHERAPY; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; LARVA; LONGITUDINAL STUDY; METABOLISM; MULTIPLE SCLEROSIS; NECATOR AMERICANUS; NONHUMAN; OOCYTE; PHASE 2 CLINICAL TRIAL (TOPIC); PSORIASIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RHEUMATOID ARTHRITIS; THERAPY WITH HELMINTHS; TRICHURIS SUIS; ANIMAL; BIOLOGICAL THERAPY; HELMINTH; HOST PATHOGEN INTERACTION; IMMUNE SYSTEM DISEASES; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; PHYSIOLOGY; PROCEDURES;

ANIMALS; BIOLOGICAL THERAPY; HELMINTHS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNOSUPPRESSION;

EID: 84908337264     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70771-6     Document Type: Review

References (149)

1. Hoeppli R The knowledge of parasites and parasitic infections from ancient times to the 17th century. Exp Parasitol 1956, 5:398-419.
2. Bundy DAP, Medley GF Immuno-epidemiology of human geohelminthiasis: ecological and immunological determinants of worm burden. Parasitology 1992, 104(suppl):S105-S119.
3. Allen JE, Maizels RM Diversity and dialogue in immunity to helminths. Nat Rev Immunol 2011, 11:375-388.
4. Fumagalli M, Pozzoli U, Cagliani R, et al. Parasites represent a major selective force for interleukin genes and shape the genetic predisposition to autoimmune conditions. J Exp Med 2009, 206:1395-1408.
5. Bach JF The effect of infections on susceptibility to autoimmune and allergic diseases. N Engl J Med 2002, 347:911-920.
6. Pearce N, Aït-Khaled N, Beasley R, et al. Worldwide trends in the prevalence of asthma symptoms: phase III of the international study of asthma and allergies in childhood (ISAAC). Thorax 2007, 62:758-766. the ISAAC Phase Three Study Group.
7. Rook GA 99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: darwinian medicine and the 'hygiene' or 'old friends' hypothesis. Clin Exp Immunol 2010, 160:70-79.
8. Hanski I, von Hertzen L, Fyhrquist N, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci USA 2012, 109:8334-8339.
9. Strachan DP Hay fever, hygiene, and household size. BMJ 1989, 299:1259-1260.
10. Preventive chemotherapy in human helminthiasis: coordinated use of drugs in control interventions: a manual for health professionals and programme managers 2006, WHO, WHO, Geneva, (accessed Feb 19, 2014). http://whqlibdoc.who.int/publications/2006/9241547103_eng.pdf.
11. Spits H, Artis D, Colonna M, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol 2013, 13:145-149.
12. Zhu J, Paul WE CD4 T cells: fates, functions, and faults. Blood 2008, 112:1557-1569.
13. Belkaid Y Regulatory T cells and infection: a dangerous necessity. Nat Rev Immunol 2007, 7:875-888.
14. Germain RN Maintaining system homeostasis: the third law of Newtonian immunology. Nat Immunol 2012, 13:902-906.
15. Ottesen EA, Hiatt RA, Cheever AW, Sotomayor ZR, Neva FA The acquisition and loss of antigen-specific cellular immune responsiveness in acute and chronic schistosomiasis in man. Clin Exp Immunol 1978, 33:37-47.
16. Ottesen EA, Weller PF, Heck L Specific cellular immune unresponsiveness in human filariasis. Immunology 1977, 33:413-421.
17. Maizels RM, Bundy DAP, Selkirk ME, Smith DF, Anderson RM Immunological modulation and evasion by helminth parasites in human populations. Nature 1993, 365:797-805.
18. Maizels RM, Yazdanbakhsh M Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 2003, 3:733-744.
19. Piessens WF, Ratiwayanto S, Tuti S, et al. Antigen-specific suppressor cells and suppressor factors in human filariasis with Brugia malayi. N Engl J Med 1980, 302:833-837.
20. Babu S, Kumaraswami V, Nutman TB Alternatively activated and immunoregulatory monocytes in human filarial infections. J Infect Dis 2009, 199:1827-1837.
21. Li Z, Liu G, Chen Y, Liu Y, Liu B, Su Z The phenotype and function of naturally existing regulatory dendritic cells in nematode-infected mice. Int J Parasitol 2011, 41:1129-1137.
22. Van Dyken SJ, Locksley RM Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. Annu Rev Immunol 2013, 31:317-343.
23. MacDonald TT Suppressor T cells, rebranded as regulatory T cells, emerge from the wilderness bearing surface markers. Gut 2002, 51:311-312.
24. Maizels RM, Smith KA Regulatory T cells in infection. Adv Immunol 2011, 112:73-136.
25. Metenou S, Nutman TB Regulatory T cell subsets in filarial infection and their function. Front Immunol 2013, 4:305.
26. Grainger JR, Smith KA, Hewitson JP, et al. Helminth secretions induce de novo T cell Foxp3 expression and regulatory function through the TGF-β pathway. J Exp Med 2010, 207:2331-2341.
27. + T cells. Eur J Immunol 2011, 41:2709-2718.
28. Correale J, Farez M, Razzitte G Helminth infections associated with multiple sclerosis induce regulatory B cells. Ann Neurol 2008, 64:187-199.
29. Van der Vlugt LE, Labuda LA, Ozir-Fazalalikhan A, et al. Schistosomes induce regulatory features in human and mouse CD1d(hi) B cells: inhibition of allergic inflammation by IL-10 and regulatory T cells. PLoS One 2012, 7:e30883.
30. Gabrilovich DI, Nagaraj S Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol 2009, 9:162-174.
31. Jewett A, Man YG, Tseng HC Dual functions of natural killer cells in selection and differentiation of stem cells; role in regulation of inflammation and regeneration of tissues. J Cancer 2013, 4:12-24.
32. Gagliani N, Magnani CF, Huber S, et al. Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 2013, 19:739-746.
33. Yazdanbakhsh M, Kremsner PG, Van Ree R Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.
34. Smits HH, Everts B, Hartgers FC, Yazdanbakhsh M Chronic helminth infections protect against allergic diseases by active regulatory processes. Curr Allergy Asthma Rep 2010, 10:3-12.
35. Leonardi-Bee J, Pritchard D, Britton J Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am J Respir Crit Care Med 2006, 174:514-523.
36. Flohr C, Quinnell RJ, Britton J Do helminth parasites protect against atopy and allergic disease?. Clin Exp Allergy 2009, 39:20-32.
37. Alcântara-Neves NM, Badaró SJ, dos Santos MC, Pontes-de-Carvalho L, Barreto ML The presence of serum anti-Ascaris lumbricoides IgE antibodies and of Trichuris trichiura infection are risk factors for wheezing and/or atopy in preschool-aged Brazilian children. Respir Res 2010, 11:114.
38. Calvert J, Burney P Ascaris, atopy, and exercise-induced bronchoconstriction in rural and urban South African children. J Allergy Clin Immunol 2010, 125:100-105.
39. Choi MH, Chang YS, Lim MK, et al. Clonorchis sinensis infection is positively associated with atopy in endemic area. Clin Exp Allergy 2011, 41:697-705.
40. Djuardi Y, Supali T, Wibowo H, et al. The development of TH2 responses from infancy to 4 years of age and atopic sensitization in areas endemic for helminth infections. Allergy Asthma Clin Immunol 2013, 9:13.
41. Hamid F, Wiria AE, Wammes LJ, et al. Risk factors associated with the development of atopic sensitization in Indonesia. PLoS One 2013, 8:e67064.
42. Mendonça LR, Veiga RV, Dattoli VC, et al. Toxocara seropositivity, atopy and wheezing in children living in poor neighbourhoods in urban Latin American. PLoS Negl Trop Dis 2012, 6:e1886.
43. Moncayo AL, Vaca M, Oviedo G, et al. Effects of geohelminth infection and age on the associations between allergen-specific IgE, skin test reactivity and wheeze: a case-control study. Clin Exp Allergy 2013, 43:60-72.
44. Rodrigues LC, Newcombe PJ, Cunha SS, et al. Early infection with Trichuris trichiura and allergen skin test reactivity in later childhood. Clin Exp Allergy 2008, 38:1769-1777. the Social Change, Asthma and Allergy in Latin AmericaAsthma and Allergy in Latin America.
45. Supali T, Djuardi Y, Wibowo H, Van Ree R, Yazdanbakhsh M, Sartono E Relationship between different species of helminths and atopy: a study in a population living in helminth-endemic area in Sulawesi, Indonesia. Int Arch Allergy Immunol 2010, 153:388-394.
46. Wördemann M, Diaz RJ, Heredia LM, et al. Association of atopy, asthma, allergic rhinoconjunctivitis, atopic dermatitis and intestinal helminth infections in Cuban children. Trop Med Int Health 2008, 13:180-186.
47. Amberbir A, Medhin G, Erku W, et al. Effects of Helicobacter pylori, geohelminth infection and selected commensal bacteria on the risk of allergic disease and sensitization in 3-year-old Ethiopian children. Clin Exp Allergy 2011, 41:1422-1430.
48. Bager P, Vinkel Hansen A, Wohlfahrt J, Melbye M Helminth infection does not reduce risk for chronic inflammatory disease in a population-based cohort study. Gastroenterology 2012, 142:55-62.
49. Cobzaru RG, Rîpă C, Leon MM, Luca MC, Ivan A, Luca M Correlation between asthma and Toxocara canis infection. Rev Med Chir Soc Med Nat Iasi 2012, 116:727-730.
50. Kanobana K, Vereecken K, Junco Diaz R, et al. Toxocara seropositivity, atopy and asthma: a study in Cuban schoolchildren. Trop Med Int Health 2013, 18:403-406.
51. Walsh MG Toxocara infection and diminished lung function in a nationally representative sample from the United States population. Int J Parasitol 2011, 41:243-247.
52. Cooper PJ Interactions between helminth parasites and allergy. Curr Opin Allergy Clin Immunol 2009, 9:29-37.
53. Leibowitz U, Antonovsky A, Medalie JM, Smith HA, Halpern L, Alter M Epidemiological study of multiple sclerosis in Israel. II. Multiple sclerosis and level of sanitation. J Neurol Neurosurg Psychiatry 1966, 29:60-68.
54. Fleming JO, Cook TD Multiple sclerosis and the hygiene hypothesis. Neurology 2006, 67:2085-2086.
55. Correale J, Farez M Association between parasite infection and immune responses in multiple sclerosis. Ann Neurol 2007, 61:97-108.
56. Correale J, Farez MF The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 2011, 233:6-11.
57. La Flamme AC, Ruddenklau K, Bäckström BT Schistosomiasis decreases central nervous system inflammation and alters the progression of experimental autoimmune encephalomyelitis. Infect Immun 2003, 71:4996-5004.
58. Sewell D, Qing Z, Reinke E, et al. Immunomodulation of experimental autoimmune encephalomyelitis by helminth ova immunization. Int Immunol 2003, 15:59-69.
59. Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 2009, 183:1577-1586.
60. Donskow-Łysoniewska K, Krawczak K, Doligalska M Heligmosomoides polygyrus: EAE remission is correlated with different systemic cytokine profiles provoked by L4 and adult nematodes. Exp Parasitol 2012, 132:243-248.
61. Solomon L, Robin G, Valkenburg HA Rheumatoid arthritis in an urban South African Negro population. Ann Rheum Dis 1975, 34:128-135.
62. Matisz CE, McDougall JJ, Sharkey KA, McKay DM Helminth parasites and the modulation of joint inflammation. J Parasitol Res 2011, 2011:942616.
63. Panda AK, Ravindran B, Das BK Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: comment on the article by Pineda et al. Arthritis Rheum 2013, 65:1402-1403.
64. Elliott DE, Urban JF, Argo CK, Weinstock JV Does the failure to acquire helminthic parasites predispose to Crohn's disease?. FASEB J 2000, 14:1848-1855.
65. Kabeerdoss J, Pugazhendhi S, Subramanian V, Binder HJ, Ramakrishna BS Exposure to hookworms in patients with Crohn's disease: a case-control study. Aliment Pharmacol Ther 2011, 34:923-930.
66. Castiglione F, Diaferia M, Morace F, et al. Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy. J Crohn's Colitis 2012, 6:324-329.
67. Chu KM, Watermeyer G, Shelly L, et al. Childhood helminth exposure is protective against inflammatory bowel disease: a case control study in South Africa. Inflamm Bowel Dis 2013, 19:614-620.
68. Weinstock JV, Elliott DE Translatability of helminth therapy in inflammatory bowel diseases. Int J Parasitol 2013, 43:245-251.
69. Zaccone P, Cooke A Helminth mediated modulation of type 1 diabetes (T1D). Int J Parasitol 2013, 43:311-318.
70. Aravindhan V, Mohan V, Surendar J, et al. Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes. Am J Trop Med Hyg 2010, 83:1336-1339.
71. Donath MY, Shoelson SE Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 2011, 11:98-107.
72. Aravindhan V, Mohan V, Surendar J, et al. Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83). PLoS Negl Trop Dis 2010, 4:e707.
73. Van den Biggelaar AH, Rodrigues LC, Van Ree R, et al. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J Infect Dis 2004, 189:892-900.
74. Elliott AM, Mpairwe H, Quigley MA, et al. Helminth infection during pregnancy and development of infantile eczema. JAMA 2005, 294:2032-2034.
75. Cooper PJ, Chico ME, Vaca MG, et al. Effect of albendazole treatments on the prevalence of atopy in children living in communities endemic for geohelminth parasites: a cluster-randomised trial. Lancet 2006, 367:1598-1603.
76. Flohr C, Tuyen LN, Quinnell RJ, et al. Reduced helminth burden increases allergen skin sensitization but not clinical allergy: a randomized, double-blind, placebo-controlled trial in Vietnam. Clin Exp Allergy 2010, 40:131-142.
77. Mpairwe H, Webb EL, Muhangi L, et al. Anthelminthic treatment during pregnancy is associated with increased risk of infantile eczema: randomised-controlled trial results. Pediatr Allergy Immunol 2011, 22:305-312.
78. Ndibazza J, Mpairwe H, Webb EL, et al. Impact of anthelminthic treatment in pregnancy and childhood on immunisations, infections and eczema in childhood: a randomised controlled trial. PLoS One 2012, 7:e50325.
79. Wiria AE, Hamid F, Wammes LJ, et al. The effect of three-monthly albendazole treatment on malarial parasitemia and allergy: a household-based cluster-randomized, double-blind, placebo-controlled trial. PLoS One 2013, 8:e57899.
80. Lynch NR, Palenque M, Hagel I, DiPrisco MC Clinical improvement of asthma after anthelminthic treatment in a tropical situation. Am J Respir Crit Care Med 1997, 156:50-54.
81. Almeida MC, Lima GS, Cardoso LS, et al. The effect of antihelminthic treatment on subjects with asthma from an endemic area of schistosomiasis: a randomized, double-blinded, and placebo-controlled trial. J Parasitol Res 2012, 2012:296856.
82. Matricardi PM, Rosmini F, Riondino S, et al. Exposure to foodborne and orofecal microbes versus airborne viruses in relation to atopy and allergic asthma: epidemiological study. BMJ 2000, 320:412-417.
83. Pelosi U, Porcedda G, Tiddia F, et al. The inverse association of salmonellosis in infancy with allergic rhinoconjunctivitis and asthma at school-age: a longitudinal study. Allergy 2005, 60:626-630.
84. von Mutius E, Vercelli D Farm living: effects on childhood asthma and allergy. Nat Rev Immunol 2010, 10:861-868.
85. Van der Werff SD, Polman K, Ponce MC, et al. Childhood atopic diseases and early life circumstances: an ecological study in Cuba. PLoS One 2012, 7:e39892.
86. Ndibazza J, Muhangi L, Akishule D, et al. Effects of deworming during pregnancy on maternal and perinatal outcomes in Entebbe, Uganda: a randomized controlled trial. Clin Infect Dis 2010, 50:531-540.
87. Webb EL, Mawa PA, Ndibazza J, et al. Effect of single-dose anthelmintic treatment during pregnancy on an infant's response to immunisation and on susceptibility to infectious diseases in infancy: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 377:52-62.
88. Endara P, Vaca M, Chico ME, et al. Long-term periodic anthelmintic treatments are associated with increased allergen skin reactivity. Clin Exp Allergy 2010, 40:1669-1677.
89. Burkhart CN, Burkhart CG Assessment of frequency, transmission, and genitourinary complications of enterobiasis (pinworms). Int J Dermatol 2005, 44:837-840.
90. Cooper PJ, Moncayo AL, Guadalupe I, et al. Repeated treatments with albendazole enhance Th2 responses to Ascaris lumbricoides, but not to aeroallergens, in children from rural communities in the Tropics. J Infect Dis 2008, 198:1237-1242.
91. Tweyongyere R, Mawa PA, Ngom-Wegi S, et al. Effect of praziquantel treatment during pregnancy on cytokine responses to schistosome antigens: results of a randomized, placebo-controlled trial. J Infect Dis 2008, 198:1870-1879.
92. Van den Biggelaar AH, Borrmann S, Kremsner P, Yazdanbakhsh M Immune responses induced by repeated treatment do not result in protective immunity to Schistosoma haematobium: interleukin (IL)-5 and IL-10 responses. J Infect Dis 2002, 186:1474-1482.
93. Wright VJ, Ame SM, Haji HS, et al. Early exposure of infants to GI nematodes induces Th2 dominant immune responses which are unaffected by periodic anthelminthic treatment. PLoS Negl Trop Dis 2009, 3:e433.
94. Figueiredo CA, Amorim LD, Alcantara-Neves NM, et al. Environmental conditions, immunologic phenotypes, atopy, and asthma: new evidence of how the hygiene hypothesis operates in Latin America. J Allergy Clin Immunol 2013, 131:1064-1068.
95. Cooper PJ, Chico M, Sandoval C, et al. Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR. Infect Immun 2001, 69:1574-1580.
96. Elias D, Wolday D, Akuffo H, Petros B, Bronner U, Britton S Effect of deworming on human T cell responses to mycobacterial antigens in helminth-exposed individuals before and after bacille Calmette-Guérin (BCG) vaccination. Clin Exp Immunol 2001, 123:219-225.
97. Lacey E Mode of action of benzimidazoles. Parasitol Today 1990, 6:112-115.
98. Skinner-Adams TS, Davis TM, Manning LS, Johnston WA The efficacy of benzimidazole drugs against Plasmodium falciparum in vitro. Trans R Soc Trop Med Hyg 1997, 91:580-584.
99. MacDonald LM, Armson A, Thompson AR, Reynoldson JA Characterisation of benzimidazole binding with recombinant tubulin from Giardia duodenalis, Encephalitozoon intestinalis, and Cryptosporidium parvum. Mol Biochem Parasitol 2004, 138:89-96.
100. Cruz MC, Edlind T beta-Tubulin genes and the basis for benzimidazole sensitivity of the opportunistic fungus Cryptococcus neoformans. Microbiology 1997, 143:2003-2008.
101. Mizuno K, Toyoda Y, Fukami T, Nakajima M, Yokoi T Stimulation of pro-inflammatory responses by mebendazole in human monocytic THP-1 cells through an ERK signaling pathway. Arch Toxicol 2011, 85:199-207.
102. Summers RW, Elliott DE, Qadir K, Urban JF, Thompson R, Weinstock JV Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003, 98:2034-2041.
103. Summers RW, Elliott DE, Urban JF, Thompson R, Weinstock JV Trichuris suis therapy in Crohn's disease. Gut 2005, 54:87-90.
104. Summers RW, Elliott DE, Urban JF, Thompson RA, Weinstock JV Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005, 128:825-832.
105. Broadhurst MJ, Leung JM, Kashyap V, et al. IL-22+ CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient. Sci Transl Med 2010, 2:60ra88.
106. Taube C, Tertilt C, Gyülveszi G, et al. IL-22 is produced by innate lymphoid cells and limits inflammation in allergic airway disease. PLoS One 2011, 6:e21799.
107. Allen JE, Wynn TA Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 2011, 7:e1002003.
108. Kirchberger S, Royston DJ, Boulard O, et al. Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model. J Exp Med 2013, 210:917-931.
109. Lu L, Nanus M, Forman S Coronado biosciences announces top-line results from its TRUST-I phase 2 clinical trial of TSO for the treatment of Crohn's Disease (accessed March 1, 2014). http://globenewswire.com/news-release/2013/10/14/580190/10052399/en/Coronado-Biosciences-Announces-Top-Line-Results-From-Its-TRUST-I-Phase-2-Clinical-Trial-of-TSO-for-the-Treatment-of-Crohn-s-Disease.html.
110. Fleming JO, Isaak A, Lee JE, et al. Probiotic helminth administration in relapsing-remitting multiple sclerosis: a phase 1 study. Mult Scler 2011, 17:743-754.
111. Bager P, Arnved J, Ronborg S, et al. Trichuris suis ova therapy for allergic rhinitis: a randomized, double-blind, placebo-controlled clinical trial. J Allergy Clin Immunol 2010, 125:123-130.
112. Summers RW, Elliott DE, Weinstock JV Trichuris suis might be effective in treating allergic rhinitis. J Allergy Clin Immunol 2010, 125:766-767.
113. Croese J, O'neil J, Masson J, et al. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 2006, 55:136-137.
114. Mortimer K, Brown A, Feary J, et al. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am J Trop Med Hyg 2006, 75:914-920.
115. Feary J, Venn A, Brown A, et al. Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study. Clin Exp Allergy 2009, 39:1060-1068.
116. Blount D, Hooi D, Feary J, et al. Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection. Am J Trop Med Hyg 2009, 81:911-916.
117. Feary JR, Venn AJ, Mortimer K, et al. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin Exp Allergy 2010, 40:299-306.
118. Daveson AJ, Jones DM, Gaze S, et al. Effect of hookworm infection on wheat challenge in celiac disease-a randomised double-blinded placebo controlled trial. PLoS One 2011, 6:e17366.
119. McSorley HJ, Gaze S, Daveson J, et al. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS One 2011, 6:e24092.
120. Gaze S, McSorley HJ, Daveson J, et al. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathog 2012, 8:e1002520.
121. Van Kruiningen HJ, West AB Potential danger in the medical use of Trichuris suis for the treatment of inflammatory bowel disease. Inflamm Bowel Dis 2005, 11:515.
122. Zou W Regulatory T cells, tumour immunity and immunotherapy. Nat Rev Immunol 2006, 6:295-307.
123. Ford AC, Peyrin-Biroulet L Opportunistic infections with anti-tumor necrosis factor-α therapy in inflammatory bowel disease: meta-analysis of randomized controlled trials. Am J Gastroenterol 2013, 108:1268-1276.
124. Gardam MA, Keystone EC, Menzies R, et al. Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 2003, 3:148-155.
125. Adjobimey T, Satoguina J, Oldenburg J, Hoerauf A, Layland LE Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-cultures. Innate Immun 2014, 20:12-23.
126. Harnett W, Harnett MM Helminth-derived immunomodulators: can understanding the worm produce the pill?. Nat Rev Immunol 2010, 10:278-284.
127. Zaccone P, Cooke A Vaccine against autoimmune disease: can helminths or their products provide a therapy?. Curr Opin Immunol 2013, 25:418-423.
128. Harnett W, Worms MJ, Kapil A, Grainger M, Parkhouse RM Origin, kinetics of circulation and fate in vivo of the major excretory-secretory product of Acanthocheilonema viteae. Parasitology 1989, 99:229-239.
129. McInnes IB, Leung BP, Harnett M, Gracie JA, Liew FY, Harnett W A novel therapeutic approach targeting articular inflammation using the filarial nematode-derived phosphorylcholine-containing glycoprotein ES-62. J Immunol 2003, 171:2127-2133.
130. Melendez AJ, Harnett MM, Pushparaj PN, et al. Inhibition of Fc epsilon RI-mediated mast cell responses by ES-62, a product of parasitic filarial nematodes. Nat Med 2007, 13:1375-1381.
131. McSorley HJ, O'Gorman MT, Blair N, Sutherland TE, Filbey KJ, Maizels RM Suppression of type 2 immunity and allergic airway inflammation by secreted products of the helminth Heligmosomoides polygyrus. Eur J Immunol 2012, 42:2667-2682.
132. Schnoeller C, Rausch S, Pillai S, et al. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J Immunol 2008, 180:4265-4272.
133. Daniłowicz-Luebert E, Steinfelder S, Kühl AA, et al. A nematode immunomodulator suppresses grass pollen-specific allergic responses by controlling excessive Th2 inflammation. Int J Parasitol 2013, 43:201-210.
134. Kuijk LM, Klaver EJ, Kooij G, et al. Soluble helminth products suppress clinical signs in murine experimental autoimmune encephalomyelitis and differentially modulate human dendritic cell activation. Mol Immunol 2012, 51:210-218.
135. Ruyssers NE, De Winter BY, De Man JG, et al. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm Bowel Dis 2009, 15:491-500.
136. Zhu B, Trikudanathan S, Zozulya AL, et al. Immune modulation by Lacto-N-fucopentaose III in experimental autoimmune encephalomyelitis. Clin Immunol 2012, 142:351-361.
137. Atochina O, Harn D Prevention of psoriasis-like lesions development in fsn/fsn mice by helminth glycans. Exp Dermatol 2006, 15:461-468.
138. Pearce EL, Pearce EJ Metabolic pathways in immune cell activation and quiescence. Immunity 2013, 38:633-643.
139. Olefsky JM, Glass CK Macrophages, inflammation, and insulin resistance. Annu Rev Physiol 2010, 72:219-246.
140. Wu D, Molofsky AB, Liang HE, et al. Eosinophils sustain adipose alternatively activated macrophages associated with glucose homeostasis. Science 2011, 332:243-247.
141. Ricardo-Gonzalez RR, Red Eagle A, Odegaard JI, et al. IL-4/STAT6 immune axis regulates peripheral nutrient metabolism and insulin sensitivity. Proc Natl Acad Sci USA 2010, 107:22617-22622.
142. Whelan M, Harnett MM, Houston KM, Patel V, Harnett W, Rigley KP A filarial nematode-secreted product signals dendritic cells to acquire a phenotype that drives development of Th2 cells. J Immunol 2000, 164:6453-6460.
143. Everts B, Perona-Wright G, Smits HH, et al. Omega-1, a glycoprotein secreted by Schistosoma mansoni eggs, drives Th2 responses. J Exp Med 2009, 206:1673-1680.
144. Atochina O, Da'dara AA, Walker M, Harn DA The immunomodulatory glycan LNFPIII initiates alternative activation of murine macrophages in vivo. Immunology 2008, 125:111-121.
145. Stahl B, Thurl S, Zeng J, et al. Oligosaccharides from human milk as revealed by matrix-assisted laser desorption/ionization mass spectrometry. Anal Biochem 1994, 223:218-226.
146. Bhargava P, Li C, Stanya KJ, et al. Immunomodulatory glycan LNFPIII alleviates hepatosteatosis and insulin resistance through direct and indirect control of metabolic pathways. Nat Med 2012, 18:1665-1672.
147. Utzinger J A research and development agenda for the control and elimination of human helminthiases. PLoS Negl Trop Dis 2012, 6:e1646.
148. Taylor-Robinson DC, Jones AP, Garner P Deworming drugs for treating soil-transmitted intestinal worms in children: effects on growth and school performance. Cochrane Database Syst Rev 2007, 4. CD000371.
149. Awasthi S, Peto R, Read S, Richards SM, Pande V, Bundy D Population deworming every 6 months with albendazole in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet 2013, 381:1478-1486. the DEVTA (Deworming and Enhanced Vitamin A) team.